The American journal of cardiology and journal of periodontology editors consensus: Eriodontitis and atherosclerotic cardiovascular disease

Journal of Periodontology

Volumn 80, Issue 7, 2009, Pages 1021-1032

  Friedewald, Vincent E ^a   Kornman, Kenneth S ^b   Beck, James D ^c   Genco, Robert ^d   Goldfine, Allison ^e   Libby, Peter ^f   Offenbacher, Steven ^c   Ridker, Paul M ^f   Van Dyke, Thomas E ^g   Roberts, William C ^h,i  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Department of Interleukin Genetics ^*  (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e JOSLIN DIABETES CENTER   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g BOSTON UNIVERSITY   (United States)

^h BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

ⁱ BAYLOR HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CARDIOLOGY; CONSENSUS; CORONARY ARTERY DISEASE; HUMAN; PERIODONTICS; PERIODONTITIS; PRACTICE GUIDELINE; PUBLICATION; RISK FACTOR; UNITED STATES;

BIOLOGICAL MARKERS; CARDIOLOGY; CONSENSUS; CORONARY ARTERY DISEASE; HUMANS; PERIODICALS AS TOPIC; PERIODONTICS; PERIODONTITIS; RISK FACTORS; UNITED STATES;

EID: 68049127577     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.097001     Document Type: Article

References (122)

1. American Academy of Periodontology.Epidemiology of periodontal diseases (position paper). J Periodontol 2005;76:1406-1419.
2. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809-1820.
3. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: Assembling the players. Periodontol 2000 1997;14:33-53.
4. Westfelt E. Rationale of mechanical plaque control. J Clin Periodontol 1996;23:263-267.
5. Bergström J, Preber H. Tobacco use as a risk factor. J Periodontol 1994;65(Suppl. 5):545-550.
6. Grossi SG, Genco RJ, Machtei EE, et al. Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol 1995;66:23-29.
7. Tomar SL, Asma S. Smoking-attributable periodon-titis in the United States: Findings from NHANES III. National Health and Nutrition Examination Survey.J Periodontol 2000;71:743-751.
8. Grossi SG, Zambon JJ, Ho AW, et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994;65:260-267.
9. Zambon JJ, Grossi SG, Machtei EE, Ho AW, Dunford R, Genco RJ. Cigarette smoking increases the risk for subgingival infection with periodontal pathogens. J Periodontol 1996;67(Suppl. 10):1050-1054.
10. Makino A, Yamada S, Okuda K, Kato T. Nicotine involved in periodontal disease through influence on cytokine levels. FEMS Immunol Med Microbiol 2008; 52:282-286.
11. Taylor GW, Borgnakke WS. Periodontal disease: Associations with diabetes, glycemic control and complications. Oral Dis 2008;14:191-203.
12. Nelson RG, Shlossman M, Budding LM, et al. Peri-odontal disease and NIDDM in Pima Indians. Diabetes Care 1990;13:836-840.
13. Taylor GW, Burt BA, Becker MP, et al. Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol 1998;69:76-83.
14. Cianciola LJ, Park BH, Bruck E, Mosovich L, Genco RJ. Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes). J Am Dent Assoc 1982;104:653-660.
15. Lalla E, Cheng B, Lal S, et al. Diabetes-related parameters and periodontal conditions in children. J Periodontal Res 2007;42:345-349.
16. Darré L, Vergnes JN, Gourdy P, Sixou M. Efficacy of periodontal treatment on glycemic control in diabetic patients: A meta-analysis of interventional studies. Diabetes Metab 2008;34:497-506.
17. Grossi SG, Skrepcinski FB, DeCaro T, et al. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol 1997;68:713-719.
18. Demmer RT, Jacobs DR Jr., Desvarieux M. Periodontal disease and incident type 2 diabetes:Results from the First National Health and Nutrition Examination Survey and its epidemiologic follow-up study. Diabetes Care 008;31:1373-1379.
19. Michalowicz BS, Aeppli D, Virag JG, et al. Periodontal findings in adult twins. J Periodontol 1991;62:293-299.
20. Kornman KS, Crane A, Wang HY, et al. The inter-leukin-1 genotype as a severity factor in adult peri-odontal disease. J Clin Periodontol 1997;24:72-77.
21. Cionca N, Giannopoulou C, Ugolotti G, Mombelli A. Amoxicillin and metronidazole as an adjunct to full-mouth scaling and root planing of chronic periodon-titis. J Periodontol 2009;80:364-371.
22. Axelsson P, Lindhe J. Effect of controlled oral hygiene procedures on caries and periodontal disease in adults.Results after 6 years. J Clin Periodontol 1981;8:239-248.
23. Axelsson P, Nyström B, Lindhe J. The long-term effect of a plaque control program on tooth mortality, caries and periodontal disease in adults.Results after 30 years of maintenance.J Clin Periodontol 2004;31: 749-757.
24. Watt RG, Marinho VC. Does oral health promotion improve oral hygiene and gingival health? Periodontol 2000 2005;37:35-47.
25. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.
26. Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke:A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction. Circulation 997;96: 3243-3247.
27. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-1143.
28. Beer FC, Hind CR, Allan RM, Maseri A, Pepys MB. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J 1982;47:239-243.
29. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 1990;65:168-172.
30. Pai JK, Pischon T, Ma J, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004;351:2599-2610. (Pubitemid 39628581)
31. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979.
32. Sesso HD, Buring JE, Rafai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA 2003;290:2945-2951.
33. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocar-dial infarction. Circulation 1998;97:2007-2011.
34. Yeh ET. CRP as a mediator of disease. Circulation 2004;109:II11-II14.
35. Scirica BM, Morrow DA. Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out. Circulation 2006;113:2128-2134.
36. Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes: Part I
37. Inoue T, Komoda H, Nonaka M, Kameda M, Uchida T, Node K. Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. Int J Cardiol 2008;124: 319- 325.
38. Natali A, L'Abbate A, Ferrannini E. Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality. Eur Heart J 2003;24:639-648.
39. Roman MJ, Moeller E, Davis A, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 2006;144:249-256.
40. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006;296:1735-1741. (Pubitemid 44547793)
41. Asanuma Y, Oeser A, Shintani AK, et al. Premature coronary-artery atherosclerosisin systemic lupus er-ythematosus. N Engl J Med 2003;349:2407-2415.
42. McMahon M, Hahn BH. Atherosclerosis and systemic lupus erythematosus: Mechanistic basis of the association.Curr Opin Immunol 007;19:633-639.
43. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farring-ton P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004;351:2611-2618.
44. Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci 2008;29:367-374.
45. Sahar S, Dwarakanath RS, Reddy A, Lanting L, Todorov I, Natarajan R. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: A novel crosstalk in the pathogenesis of atherosclerosis. Circ Res 2005;96:1064-1071.
46. Kainulainen K, Perola M, Terwilliger J, et al. Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension 1999; 33:844-849.
47. Ferrario CM, Strawn WB. Role of renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 2006;98:121-128.
48. Lim HS, Lip GY. Interleukin-15 in hypertension: Further insights into inflammation and vascular disease. Am J Hypertens 2005;18:1017-1018.
49. Kampus P, Muda P, Kals J, et al. The relationship between inflammation and arterial stiffness in patients with essential hypertension. Int J Cardiol 2006;112:46-51.
50. Karthikeyan VJ, Lip GY. Alpha 1-microglobulin: A further insight to inflammation in hypertension? Am J Hypertens 2007;20:1022-1023.
51. Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 2005;46:1118-1122.
52. Engström G, Janzon L, Berglund O, et al. Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol 2002;22:2054-2058. (Pubitemid 36025214)
53. August P, Suthanthiran M. Transforming growth factor beta signaling, vascular remodeling, and hypertension. N Engl J Med 2006;354:2721-2723.
54. Lakoski SG, Herrington DM, Siscovick DM, Hulley SB. C-reactive protein concentration and incident hypertension in young adults. Arch Intern Med 2006; 166:345-349.
55. Ridker PM, Danielson E, Fonseca FA, et al. Ros-uvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207.
56. Libby P, Ridker PM. Inflammation and atherothrombo-sis: From population biology and bench research to clinical practice. J Am Coll Cardiol 2006;48:A33-A46.
57. Granger DN, Vowinkel T, Petnehazy T. Modulation of the inflammatory response in cardiovascular disease. Hypertension 2004;43:924-931.
58. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, Van der Velden UV. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 2000;71:1528-1534.
59. Beck JD, Eke P, Heiss G, et al. Periodontal disease and coronary heart disease: A reappraisal of the exposure. Circulation 2005;112:19-24.
60. Danesh J. Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus:Meta-analyses of prospective studies.Am Heart J 1999;138:S434-S437. (Pubitemid 29523228)
61. Persson GR, Persson RE. Cardiovascular disease and periodontitis: An update on the associations and risk. J Clin Periodontol 2008;35(Suppl. 8):362-379.
62. Dietrich T, Jimenez M, Krall Kaye EA, Vokonas PS, Garcia RI. Age-dependent associations between chronic periodontitis/edentulism and risk of coronary heart disease. Circulation 2008;117:1668-1674.
63. Amabile N, Susini G, Pettenati-Soubayroux I, et al. Severity of periodontal disease correlates to inflammatory systemic status and independently predicts the presence and angiographic extent of stable coronary artery disease. J Intern Med 2008;263:644-652.
64. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK,for the Cardiovascular Health Study Collaborative Research Group.Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340:14-22.
65. Beck JD, Elter JR, Heiss G, Couper D, Mauriello SM, Offenbacher S. Relationship of periodontal disease to carotid artery intima-media wall thickness:The Atherosclerosis Risk in Communities (ARIC) Study.Arterioscler Thromb Vasc Biol 2001;21:1816-1822. (Pubitemid 34219786)
66. Cairo F, Castellani S, Gori AM, et al. Severe peri-odontitisinyoung adultsisassociated with sub-clinical atherosclerosis. J Clin Periodontol 2008;35:465-472.
67. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Periodontal disease and coronary heart disease risk. JAMA 2000;284:1406-1410.
68. Kinane DF, Lowe GD. How periodontal disease may contribute to cardiovascular disease. Periodontol 2000 2000;23:121-126.
69. Herzberg MC, Meyer MW. Effects of oral flora on platelets: Possible consequences in cardiovascular disease. J Periodontol 1996;67(Suppl.):1138-1142.
70. Sahingur SE, Sharma A, Genco RJ, de Nardin ED. Association of increased levels of fibrinogen and the -455G/A fibrinogen gene polymorphism with chronic periodontitis. J Periodontol 2003;74:329-337.
71. Harris RP, Helfand M, Woolf SH, et al.Current methods of the US Preventive Services Task Force:A review of the process. Am J Prev Med 2001; 20(Suppl. 3):21-35.
72. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. BMJ 1993;306:688-691. (Pubitemid 23070231)
73. Mattila KJ, Valtonen VV, Nieminen M, Huttunen JK. Dental infection and the risk of new coronary events: Prospective study of patients with documented coronary artery disease. Clin Infect Dis 1995;20: 588-592.
74. Joshipura KJ, Rimm EB, Douglass CW, Trichopoulos D, Ascherio A, Willett WC. Poor oral health and coronary heart disease. J Dent Res 1996;75:1631-1636.
75. Wu T, Trevisan M, Genco R, Dorn J, Falkner K, Sempos C. Periodontal disease as a risk factor for CVD, CHD, and stroke: The First National Health and Nutrition Examination Survey (NHANES) and its follow-up study. Circulation 1999;99:1109-1125.
76. Howell TH, Ridker PM, Ajani UA, Hennekens CH, Christen WG. Periodontal disease and risk of subsequent cardiovascular disease in US male physicians. J Am Coll Cardiol 2001;37:445-450.
77. Loesche WJ, Schork A, Terpenning MS, Chen YM, Dominguez BL, Grossman N. Assessing the relationship between dental disease and coronary heart disease in elderly US veterans. J Am Dent Assoc 1998; 129:301-311.
78. Arbes SJ Jr., Slade GD, Beck JD. Association between extent of periodontal attachment loss and self-reported history of heart attack: An analysis of NHANES III data. J Dent Res 1999;78:1777-1782.
79. Buhlin K, Gustafsson A, Hakansson J, Klinge B. Oral health and cardiovascular disease in Sweden. J Clin Periodontol 2002;29:254-259.
80. Buhlin K, Gustafsson A, Hakansson J, Klinge B. Self-reported oral health, dental care habits and cardiovascular disease in an adult Swedish population. Oral Health Prev Dent 2003;1:291-299.
81. Elter JR, Champagne CM, Offenbacher S, Beck JD. Relationship of periodontal disease and tooth loss to prevalence of coronary heart disease. J Periodontol 2004;75:782-790.
82. Malthaner SC, Moore S, Mills M, et al. Investigation of the association between angiographically defined coronary artery disease and periodontal disease. J Periodontol 2002;73:1169-1176.
83. Geerts SO, Legrand V, Charpentier J, Albert A, Rompen EH. Further evidence of the association between periodontal conditions and coronary artery disease. J Periodontol 2004;75:1274-1280.
84. Buhlin K, Gustafsson A, Ahnve S, Janszky I, Tabrizi F, Klinge B. Oral health in women with coronary heart disease. J Periodontol 2005;76:544-550.
85. Briggs JE, McKeown PP, Crawford VLS, et al. Angio-graphically confirmed coronary heart disease and periodontal disease in middle-aged males. J Periodontol 2006;77:95-102.
86. Spahr A, Klein E, Khuseyinova N, et al. Periodontal infections and coronary heart disease: Role of peri-odontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study. Arch Intern Med 2006; 166:554-559.
87. Wu T, Trevisan M, Genco RJ, Falkner KL, Dorn JP, Sempos CT. Examination of the relation between periodontal health status and cardiovascular risk factors: Serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrino-gen. Am J Epidemiol 2000;151:273-282.
88. Glurich I, Grossi S, Albini B, et al. Systemic inflammation in cardiovascular and periodontal disease: Comparative study. Clin Diagn Lab Immunol 2002; 9:425-432.
89. Andriankaja OM, Genco RJ, Dorn J, et al. Periodontol disease and risk of myocardial infarction: The role of gender and smoking. Eur J Epidemiol 2007;22:699-705.
90. Morrison HI, Ellison LF, Taylor GW. Periodontal disease and risk of fatal coronary heart and cere-brovascular diseases. J Cardiovasc Risk 1999;6: 7-11.
91. Luoto R, Pekkanen J, Uutela A, Tuomilehto J. Cardiovascular risks and socioeconomic status: Differences between men and women in Finland. J Epidemiol Community Health 1994;48:348-354.
92. Humphrey LL, Fu R, Buckley DI, Freeman M, Helfand MJ. Periodontal disease and coronary heart disease incidence: A systematic review and meta-analysis. J Gen Intern Med 2008;23:2079-2086.
93. Bahekar AA, Singh S, Saha S, Molnar J, Arora R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: A meta-analysis. Am Heart J 2007;154:830-837.
94. Wu T, Trevisan M, Genco RJ, Dorn JP, Falkner KL, Sempos CT. Periodontal disease and risk of cerebro-vascular disease: The First National Health and Nutrition Examination Survey and its follow-up study. Arch Intern Med 2000;160:2749-2755.
95. Joshipura KJ, Hung HC, Rimm EB, Willett WC, Ascherio A. Periodontal disease, tooth loss, and incidence of ischemic stroke. Stroke 2003;34:47-52.
96. Chen YW, Umeda M, Nagasawa T, et al. Periodontitis may increase the risk of peripheral arterial disease. Eur J Vasc Endovasc Surg 2008;35:153-158.
97. Bloemenkamp DG, van den Bosch MA, Mali WP, et al. Novel risk factors for peripheral arterial disease in young women. Am J Med 2002;113:462-467.
98. Linden GJ, McClean K, Young I, Evans A, Kee F. Persistently raised C-reactive protein levels are associated with advanced periodontal disease. J Clin Periodontol 2008;35:741-747.
99. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in ath-eromatous plaques. J Periodontol 2000;71:1554-1560.
100. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008;35: 277-290.
101. Tonetti MS, D'Aiuto F, Nibali L, et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007;356:911-920.
102. Al-Zahrani MS, Bissada NF, Borawskit EA. Obesity and periodontal disease in young, middle-aged, and older adults. J Periodontol 2003;74:610-615.
103. Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y. A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol 2005;76(Suppl. 11):2075-2084.
104. Lösche W, Marshal GJ, Apatzidou DA, Krause S, Kocher T, Kinane DF. Lipoprotein-associated phos-pholipase A2 and plasma lipids in patients with destructive periodontal disease. J Clin Periodontol 2005;32:640-644.
105. Morita M, Horiuchi M, Kinoshita Y, Yamamoto T, Watanabe T. Relationship between blood triglyceride levels and periodontal status. Community Dent Health 2004;21:32-36.
106. Holmlund A, Holm G, Lind L. Severity of periodontal disease and number of remaining teeth are related to the prevalence of myocardial infarction and hypertension in a study based on 4,254 subjects. J Periodontol 2006;77:1173-1178.
107. Al-Emadi A, Bissada N, Farah C, Siegel B, Al-Zaharani M. Systemic diseases among patients with and without alveolar bone loss. Quintessence Int 2006;37:761-765.
108. Engström S, Gahnberg L, Högberg H, Svärdsudd K. Association between high blood pressure and deep periodontal pockets: A nested case-referent study. Ups J Med Sci 2007;112:95-103.
109. Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: The Reynolds Risk Score for men. Circulation 2008; 118:2243-2251.
110. Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: A systematic review. J Am Coll Cardiol 2005;45:1563-1569.
111. Ridker PM, Morrow DA, Rose LM, Rifai N, Cannon CP, Braunwald E. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/L: An analysis of the PROVE-IT TIMI-22 trial. J Am Coll Cardiol 2005;45: 1644-1648.
112. Grundy SM, Cleeman JI, Mertz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-239.
113. National Institutes of Health. Your guide to lowering your blood pressure with DASH.Available at: http:// www.nhlbi.nih.gov/health/public/heart/hbp/dash/ new-dash.pdf. Accessed February25, 2009.
114. Missouris GG, Kalaitzidis RG, Cappuccio FP, MacGregor GA. Gingival hyperplasia caused by calcium channel blockers. J Hum Hypertens 2000;14:155-156.
115. Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of gingival overgrowth induced by calcium channel blockers: A community-based study. J Periodontol 1999;70:63-67.
116. Routray SN, Mishra TK, Pattnaik UK, Satapathy C, Mishra CK, Behera M. Amlodipine-induced gingival hyperplasia. J Assoc Physicians India 2003;51:818-819.
117. Jorgensen MG. Prevalence of amlodipine-related gin-gival hyperplasia. J Periodontol 1997;68:676-678.
118. Matharu MS, van Vliet JA, Ferrari MD, Goadsby PJ. Verapamil induced gingival enlargement in cluster headache. J Neurol Neurosurg Psychiatry 2005;76: 124-127.
119. Miller CS, Damm DD. Incidence of verapamil-induced gingival hyperplasia in a dental population. J Periodontol 1992;63:453-456.
120. Li B, Sun W, Yong J. The effect of nifedipine on the expression of type I collagen in gingival fibroblasts. J Nanging Univ 2008;22:92-95.
121. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752.
122. Offenbacher S, Beck JD, Moss K, et al. Results from the Periodontitis and Vascular Events (PAVE) study: A pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol 2009;80:190-201.